RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Oxford Biodynamics Stock

Oxford Biodynamics P/E 2024

Oxford Biodynamics P/E

-86.71

Ticker

OBD.L

ISIN

GB00BD5H8572

WKN

A2DH0R

As of Nov 10, 2024, Oxford Biodynamics's P/E ratio was -86.71, a 4,561.83% change from the -1.86 P/E ratio recorded in the previous year.

The Oxford Biodynamics P/E history

Oxford Biodynamics Aktienanalyse

What does Oxford Biodynamics do?

Oxford Biodynamics PLC is a company specialized in the development and application of epigenetic technologies. It was founded in 2007 in Oxford, United Kingdom and has since then had an impressive track record in researching and developing new methods for the detection and treatment of diseases. The business model of Oxford Biodynamics is to utilize its proprietary technology platform, EpiSwitch®, to offer validation and screening services to customers in the pharmaceutical and biotech industries. Oxford Biodynamics' technology platform utilizes epigenetic information to diagnose and predict diseases. The company also uses its technology to identify biomarkers that provide unique insights into the biological processes associated with specific diseases. Oxford Biodynamics operates in three main areas: diagnostics, research and development, and nanoparticle technology. In the diagnostics field, the company offers blood tests for early detection of breast cancer and other types of cancer. The tests utilize a combination of epigenetic signatures and artificial intelligence to deliver results. Oxford Biodynamics is also developing a test to aid in the diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's. In the research and development field, Oxford Biodynamics collaborates closely with pharmaceutical and biotech companies to identify epigenetic signatures specific to certain diseases. The company has already worked with major pharmaceutical companies to test the effectiveness of drugs in treating lung cancer and breast cancer. Oxford Biodynamics has also started a collaboration with the John Radcliffe Hospital in Oxford to develop new epigenetics-based methods for predicting premature births. In the nanoparticle technology field, the company utilizes its expertise in epigenetics to develop new technologies that enhance drug delivery and increase the therapeutic effects of medications. The company is currently developing a new type of nanoparticles specifically designed to target cancer cells. These nanoparticles are able to selectively concentrate on cancer cells and directly enter the targeted tissue, minimizing unwanted side effects and maximizing effectiveness. Overall, Oxford Biodynamics is a leading company in epigenetics research and technology development. The company has already made significant advancements in developing new diagnostic and therapeutic methods for various diseases and is constantly working to improve its technologies and expand its product range. The future of the company looks very promising as epigenetics becomes increasingly important in medical research and diagnostics, and Oxford Biodynamics is one of the leading companies in this field. Oxford Biodynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Oxford Biodynamics's P/E Ratio

The Price to Earnings (P/E) Ratio of Oxford Biodynamics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Oxford Biodynamics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Oxford Biodynamics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Oxford Biodynamics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Oxford Biodynamics stock

What is the price-to-earnings ratio of Oxford Biodynamics?

The price-earnings ratio of Oxford Biodynamics is currently -86.71.

How has the price-earnings ratio of Oxford Biodynamics changed compared to last year?

The price-to-earnings ratio of Oxford Biodynamics has increased by 4,561.83% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Oxford Biodynamics high compared to other companies?

Yes, the price-to-earnings ratio of Oxford Biodynamics is high compared to other companies.

How does an increase in the price-earnings ratio of Oxford Biodynamics affect the company?

An increase in the price-earnings ratio of Oxford Biodynamics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Oxford Biodynamics affect the company?

A decrease in the price-earnings ratio of Oxford Biodynamics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Oxford Biodynamics?

Some factors that influence the price-earnings ratio of Oxford Biodynamics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Oxford Biodynamics pay?

Over the past 12 months, Oxford Biodynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oxford Biodynamics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Oxford Biodynamics?

The current dividend yield of Oxford Biodynamics is .

When does Oxford Biodynamics pay dividends?

Oxford Biodynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oxford Biodynamics?

Oxford Biodynamics paid dividends every year for the past 0 years.

What is the dividend of Oxford Biodynamics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oxford Biodynamics located?

Oxford Biodynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oxford Biodynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oxford Biodynamics from 11/10/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 11/10/2024.

When did Oxford Biodynamics pay the last dividend?

The last dividend was paid out on 11/10/2024.

What was the dividend of Oxford Biodynamics in the year 2023?

In the year 2023, Oxford Biodynamics distributed 0 GBP as dividends.

In which currency does Oxford Biodynamics pay out the dividend?

The dividends of Oxford Biodynamics are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Oxford Biodynamics

Our stock analysis for Oxford Biodynamics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oxford Biodynamics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.